We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Transparent Skull Implant Provides Access to the Brain

By HospiMedica International staff writers
Posted on 01 Oct 2013
A novel transparent skull implant could make available a "window to the brain,” providing new treatment strategies for those with life-threatening neurological disorders.

Researchers from the University of California, Riverside (UCR; USA) created the new implant using nanocrystalline yttria-stabilized zirconia (nc-YSZ), a ceramic material that is currently used in dental crowns and hip implants. More...
The researchers then used current-activated, pressure-assisted densification (CAPAD) to reduce the porosity of the material to nanometric dimensions, thus reducing the optical scattering to turn the nc-YSZ to transparent. The transparent YSZ was then polished, heated, and slow cooled to toughen the material, and cut into rectangular implants of 2.1 x 4.2 x 0.2 mm3.

The researchers then performed right-sided craniectomies on anesthetized mice, fixing the implants to the surrounding skull with dental cement. Using optical coherence tomography (OCT) imaging of the underlying brain, they showed that signal strength was improved when imaging through nc-YSZ implants, relative to the native control calvarium. The researchers added that signal strength at nearly every depth was much higher when imaging through the nc-YSZ implant. The study was published in the September 2013 issue of Nanomedicine: Nanotechnology, Biology and Medicine.

“This is a crucial first step towards an innovative new concept that would provide a clinically-viable means for optically accessing the brain, on-demand, over large areas, and on a chronically-recurring basis, without need for repeated craniectomies,” said study coauthor associate professor of biomedical sciences Kevin Binder, MD, PhD. “Similarly, it may enable chronic monitoring and more precise targeting of photodynamic therapies for residual gliomas, which could prolong survival and improve quality of life for many suffering from brain cancer.”

Transparent cranial implants could serve as a critical enabler for laser-based diagnosis and treatment of many neurological disorders. However, the intrinsic brittleness of current transparent implants predisposes them to catastrophic fracture-based failure, thus limiting opportunity for clinical translation. The new nc-YSZ transparent implants could address this issue since it is a tough ceramic with well-proven biocompatibility in other chronic implantation applications.

Related Links:

University of California, Riverside



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.